Synthetic Biology & BioManufacturing

What's Happening

Synthetic biology — the engineering of biological systems to create new materials, foods, medicines, and fuels — is transitioning from academic research to commercial reality. The cost of DNA synthesis has fallen 1000x in the past decade, and AI tools like AlphaFold have revolutionized protein structure prediction. Companies are now programming microorganisms to produce spider silk, leather alternatives, sustainable dyes, pharmaceutical ingredients, and even meat proteins through precision fermentation. The biomanufacturing market is being catalyzed by consumer demand for sustainable alternatives, pharmaceutical supply chain vulnerabilities exposed during COVID, and advances in lab automation that enable high-throughput experimentation. Startups like Ginkgo Bioworks are building the platform layer — acting as the AWS of biology by providing organism engineering services to other companies. The opportunity for software founders lies in the tooling: lab information management systems (LIMS), experiment design optimization, bioprocess simulation, and supply chain management for biological products. The design-build-test-learn cycle in biology is becoming increasingly software-driven, and the companies building the computational tools will capture significant value.

Interest Over Time

Market Size